To access this element change to forms mode OFF
Grant Award View - GA29828
RIPK1: Master Regulator of Inflammation
GA ID:
GA29828
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$832,086.72
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
RIPK1: Master Regulator of Inflammation
Purpose:
The protein RIPK1 plays a critical, and complex, role in regulating the severity of an inflammatory response. Pre-clinical data suggests that inhibiting RIPK1 kinase activity may be used to treat inflammatory diseases (e.g. psoriasis), and many pharmaceutical companies are developing RIPK1 inhibitors. As it is still unclear how RIPK1 regulates inflammation, we have generated RIPK1 knock-in mice that allow us to precisely and genetically address this lacunae and lead to more effective treatments.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1163581
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA